Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Ultrastructure of SARS-CoV, FIPV, and MHV revealed by electron cryomicroscopy.

Neuman BW, Adair BD, Yoshioka C, Quispe JD, Milligan RA, Yeager M, Buchmeier MJ.

Adv Exp Med Biol. 2006;581:181-5. No abstract available.

PMID:
17037527
2.

Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins.

Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR.

J Virol. 2004 Sep;78(18):9977-86.

3.

Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.

Hsieh PK, Chang SC, Huang CC, Lee TT, Hsiao CW, Kou YH, Chen IY, Chang CK, Huang TH, Chang MF.

J Virol. 2005 Nov;79(22):13848-55.

4.

Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis.

Qin L, Xiong B, Luo C, Guo ZM, Hao P, Su J, Nan P, Feng Y, Shi YX, Yu XJ, Luo XM, Chen KX, Shen X, Shen JH, Zou JP, Zhao GP, Shi TL, He WZ, Zhong Y, Jiang HL, Li YX.

Acta Pharmacol Sin. 2003 Jun;24(6):489-96.

5.

Switching species tropism: an effective way to manipulate the feline coronavirus genome.

Haijema BJ, Volders H, Rottier PJ.

J Virol. 2003 Apr;77(8):4528-38.

6.

The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication.

Tylor S, Andonov A, Cutts T, Cao J, Grudesky E, Van Domselaar G, Li X, He R.

Can J Microbiol. 2009 Mar;55(3):254-60. doi: 10.1139/w08-139.

PMID:
19370068
7.

Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein.

You J, Dove BK, Enjuanes L, DeDiego ML, Alvarez E, Howell G, Heinen P, Zambon M, Hiscox JA.

J Gen Virol. 2005 Dec;86(Pt 12):3303-10.

PMID:
16298975
8.

Production and characterization of monoclonal antibodies against the nucleocapsid protein of SARS-CoV.

Fang Y, Pekosz A, Haynes L, Nelson EA, Rowland RR.

Adv Exp Med Biol. 2006;581:153-6. No abstract available.

PMID:
17037523
9.

Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus.

Fukushima A, Fukuda N, Lai Y, Ueno T, Moriyama M, Taguchi F, Iguchi A, Shimizu K, Kuroda K.

Intervirology. 2009;52(2):92-9. doi: 10.1159/000215946. Epub 2009 May 7.

PMID:
19420961
10.

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

Bosch BJ, Martina BE, Van Der Zee R, Lepault J, Haijema BJ, Versluis C, Heck AJ, De Groot R, Osterhaus AD, Rottier PJ.

Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60. Epub 2004 May 18.

11.

Severe acute respiratory syndrome coronavirus persistence in Vero cells.

Palacios G, Jabado O, Renwick N, Briese T, Lipkin WI.

Chin Med J (Engl). 2005 Mar 20;118(6):451-9.

PMID:
15788125
12.

Activation of NF-kappaB by the full-length nucleocapsid protein of the SARS coronavirus.

Liao QJ, Ye LB, Timani KA, Zeng YC, She YL, Ye L, Wu ZH.

Acta Biochim Biophys Sin (Shanghai). 2005 Sep;37(9):607-12.

13.

Comparative in vivo analysis of the nsp15 endoribonuclease of murine, porcine and severe acute respiratory syndrome coronaviruses.

Cao J, Zhang X.

Virus Res. 2012 Aug;167(2):247-58. doi: 10.1016/j.virusres.2012.05.006. Epub 2012 May 19.

14.

Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.

Yasui F, Kai C, Kitabatake M, Inoue S, Yoneda M, Yokochi S, Kase R, Sekiguchi S, Morita K, Hishima T, Suzuki H, Karamatsu K, Yasutomi Y, Shida H, Kidokoro M, Mizuno K, Matsushima K, Kohara M.

J Immunol. 2008 Nov 1;181(9):6337-48.

15.

An interaction between the nucleocapsid protein and a component of the replicase-transcriptase complex is crucial for the infectivity of coronavirus genomic RNA.

Hurst KR, Ye R, Goebel SJ, Jayaraman P, Masters PS.

J Virol. 2010 Oct;84(19):10276-88. doi: 10.1128/JVI.01287-10. Epub 2010 Jul 21.

16.

Ultrastructural characterization of SARS coronavirus.

Goldsmith CS, Tatti KM, Ksiazek TG, Rollin PE, Comer JA, Lee WW, Rota PA, Bankamp B, Bellini WJ, Zaki SR.

Emerg Infect Dis. 2004 Feb;10(2):320-6.

17.

Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein of SARS coronavirus.

Timani KA, Liao Q, Ye L, Zeng Y, Liu J, Zheng Y, Ye L, Yang X, Lingbao K, Gao J, Zhu Y.

Virus Res. 2005 Dec;114(1-2):23-34. Epub 2005 Jun 29.

PMID:
15992957
18.

Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition.

Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ.

Virology. 2007 Apr 25;361(1):18-26. Epub 2007 Feb 21.

19.
20.

A SARS-CoV-specific protein enhances virulence of an attenuated strain of mouse hepatitis virus.

Pewe L, Zhou H, Netland J, Tangadu C, Olivares H, Shi L, Look D, Gallagher T, Perlman S.

Adv Exp Med Biol. 2006;581:493-8. No abstract available.

PMID:
17037583

Supplemental Content

Support Center